NasdaqGM:ASSTMedical Equipment
Strive (ASST) Stock May Be Undervalued As Profitability Questions Persist
Strive’s share price has fallen sharply in recent years, yet the stock still screens as undervalued on market multiples while its broader valuation checks remain weak. This leaves investors with a mixed message on what the current price really offers.
Strive has declined about 90% over the past 3 years, which signals that the market has heavily reset expectations for the business.
Any improvement in Strive’s ability to turn revenue into consistent cash flow can help support the current...